Reversal of Ketamine Pharmacodynamic Effects With Naloxone
|ClinicalTrials.gov Identifier: NCT00921765|
Recruitment Status : Suspended (Problems with patient recruitment)
First Posted : June 16, 2009
Last Update Posted : April 6, 2017
Ullevaal University Hospital
University of Oslo
Information provided by (Responsible Party):
Lasse Ansgar Skoglund, Oslo University Hospital
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Suspended|
|Estimated Primary Completion Date :||December 2017|
|Estimated Study Completion Date :||December 2017|
Gear RW, Miaskowski C, Gordon NC, Paul SM, Heller PH, Levine JD. Kappa-opioids produce significantly greater analgesia in women than in men. Nat Med. 1996 Nov;2(11):1248-50.
Hustveit O, Maurset A, Oye I. Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors. Pharmacol Toxicol. 1995 Dec;77(6):355-9.
Mathisen LC, Skjelbred P, Skoglund LA, Oye I. Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain. Pain. 1995 May;61(2):215-20.